Related Experiment Video
Updated: Jan 27, 2026

11:40
Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics
Published on: June 23, 2022
2.9K
Proteomic Analysis of the β-Arrestin Interactomes.
Yang Zhao1, Kunhong Xiao2,3,4
1Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|March 29, 2019
Summary
This study details mass spectrometry methods for identifying β-arrestin interactomes. These techniques, including co-immunoprecipitation and SILAC, enable global and quantitative analysis of protein-protein interactions.
Area of Science:
- Proteomics
- Cellular Signaling
- Molecular Biology
Background:
- Protein-protein interactions are fundamental to cellular functions and signaling pathways.
- Mass spectrometry (MS)-based proteomics offers high-throughput methods for identifying protein interaction networks.
- Characterizing the β-arrestin interactome is essential for understanding its role in cellular processes.
Purpose of the Study:
- To describe proteomic methodologies for characterizing the complete set of proteins associated with β-arrestins (β-arrestin interactomes).
- To provide a framework for identifying protein binding partners in a global and high-throughput manner.
- To detail quantitative approaches for analyzing changes in binding partners under varying conditions.
Main Methods:
- Co-immunoprecipitation (co-IP) to isolate β-arrestin signaling complexes.
- Protease digestion followed by liquid chromatography/tandem mass spectrometry (LC/MS/MS) for protein identification.
- Stable isotope labeling by amino acids in cell culture (SILAC) for quantitative interactome analysis.
Main Results:
- The described methods enable comprehensive identification of proteins interacting with β-arrestins.
- The workflow allows for the characterization of the entire β-arrestin interactome.
- Quantitative SILAC analysis provides insights into condition-dependent changes in protein binding partners.
Conclusions:
- Mass spectrometry-based proteomic approaches are powerful tools for dissecting complex protein interaction networks.
- The presented methods facilitate a detailed understanding of β-arrestin-mediated signaling pathways.
- These techniques are valuable for global and quantitative analysis of protein interactomes in various biological contexts.
Keywords:
GPCRInteractomeLC/MSLC/MS/MSMass spectrometryProteomeProteomicsQuantitative proteomicsSILACStable isotope labeling by amino acids in cell cultureβ-ArrestinMore Related Videos
Related Concept Videos
Proteomics
9.5K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.5K
TGF - β Signaling Pathway
10.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
Adrenergic Receptors: β Subtype
3.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.7K
Antianginal Drugs: Nitrates and β-Blockers
1.6K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.6K
Antihypertensive Drugs: Types of β-Blockers
1.6K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.6K
Heart Failure Drugs: β-Blockers
866
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
866

